Work

WS06-5 Change in low-dose chest Computed Tomography (CT) scores after 72 weeks of tezacaftor/ivacaftor (TEZ/IVA) in patients (pts) with cystic fibrosis and ppFEV1 ≥70%: an exploratory phase 2 study

Year: 2019

Type: article

Source: Journal of Cystic Fibrosis

DOI: 10.1016/s1569-1993(19)30152-3

Authors: C. Wainwright, S. Stick, J. Goldin, J. Lekstrom-Himes, L. Wang, D. Campbell, L.T. Wang, R.S. Harris, C.A. Owen, A. Brody

Institution: Eloxx Pharmaceuticals (United States)

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2947216005

FWCI: 0.185

Cites:

Cited by: 3

Related to: 10